GC
CHRS icon

Globeflex Capital’s Coherus Oncology CHRS Stock Holding History

Globeflex Capital’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-28,233
Closed -$491K – 460
2020
Q4 		$491K Sell
28,233
-657
-2% -$11.7K 0.1% 295
2020
Q3 		$530K Buy
28,890
+1,521
+6% +$28.3K 0.14% 245
2020
Q2 		$489K Buy
27,369
+21,434
+361% +$363K 0.12% 275
2020
Q1 		$96K Hold
5,935
– – 0.03% 421
2019
Q4 		$107K Buy
+5,935
New +$109K 0.02% 432
2017
Q1 		– Sell
-16,631
Closed -$468K – 474
2016
Q4 		$468K Buy
+16,631
New +$465K 0.12% 260
2015
Q2 		– Sell
-6,121
Closed -$187K – 522
2015
Q1 		$187K Buy
+6,121
New +$158K 0.04% 361

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Globeflex Capital's CHRS Position: Q1 2021 in Review

Globeflex Capital sold out of Coherus Oncology (CHRS) in Q1 2021, closing a stake of 28,233 shares — an estimated $491K sold.

Globeflex Capital first reported a position in CHRS in Q1 2015 and held it in 7 quarters. The position peaked at $530K in Q3 2020. 205 funds tracked by Wall St. Rank hold CHRS as of Q1 2021.

  • Globeflex Capital reported no remaining Coherus Oncology position as of Q1 2021 after selling out during the quarter.
  • Globeflex Capital sold 28,233 Coherus Oncology shares in Q1 2021, an estimated $491K.
  • Globeflex Capital first reported a position in Coherus Oncology in Q1 2015 and held it in 7 quarters.
  • Globeflex Capital's Coherus Oncology position peaked at $530K in Q3 2020.
  • 205 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2021.

Based on Globeflex Capital's 13F filing for Q1 2021, filed 14 May 2021.